SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-254229
Filing Date
2024-11-08
Accepted
2024-11-08 17:00:29
Documents
6
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A d849286dpre14a.htm PRE 14A 580723
2 GRAPHIC g849286g00a02.jpg GRAPHIC 36409
3 GRAPHIC g849286g11m01.jpg GRAPHIC 222753
4 GRAPHIC g849286g11m02.jpg GRAPHIC 279754
5 GRAPHIC g849286g43c59.jpg GRAPHIC 138587
6 GRAPHIC g849286g82l50.jpg GRAPHIC 137195
  Complete submission text file 0001193125-24-254229.txt   1679408
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36571 | Film No.: 241441597
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)